CLINICAL ROLE -
Opinion
Video
Author(s):
The panel of pneumococcal vaccination experts offer their concluding insights and perspectives on the current landscape of pneumococcal vaccines.
ACIP Votes to Recommend Pneumococcal 21-Valent Conjugate Vaccine for Adult Populations
FDA Approves V116 for Prevention of Invasive Pneumococcal Disease and Pneumonia
Study: Larger Lifetime Cost Savings for V116 Compared With PCV20
Quality Improvement Methodology Increases Pneumococcal Vaccination for Patients With Rheumatic Diseases
Study: Contact With Children Causes Transmission of Pneumococcal Disease Among Older Adults
Study: 3 Doses of PCV13 Prevents Vaccine-Type Invasive Pneumococcal Disease in Children